Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Novartis
Novartis
Syndax Pharmaceuticals
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Novartis
Hope Biosciences Research Foundation
Novartis
Gruppo Italiano Malattie EMatologiche dell'Adulto
Polish Lymphoma Research Group
Sanofi
First Affiliated Hospital of Zhejiang University
Shanghai Jiao Tong University School of Medicine
Novartis
University of Milano Bicocca
Eli Lilly and Company
Eli Lilly and Company
Fundación Teófilo Hernando, Spain
University College, London
MetrioPharm AG
M.D. Anderson Cancer Center
Mundipharma Research GmbH & Co KG
University Hospital Southampton NHS Foundation Trust
National Institutes of Health Clinical Center (CC)
Bristol-Myers Squibb
University of California, San Diego
Gilead Sciences
University of Pittsburgh
Mirati Therapeutics Inc.
Sanofi
Ann & Robert H Lurie Children's Hospital of Chicago
Chronic Lymphocytic Leukemia Research Consortium